Flexion Therapeutics
FLXN
#7339
Rank
NZ$0.76 B
Marketcap
NZ$15.30
Share price
0.00%
Change (1 day)
7,814.07%
Change (1 year)

Earnings for Flexion Therapeutics (FLXN)

Earnings in 2021 (TTM): -NZ$0.12 Billion

According to Flexion Therapeutics 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2020 the company made an earning of -NZ$0.16 Billion, an increase over its 2019 earnings that were of -NZ$0.23 Billion.

Earnings history for Flexion Therapeutics from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$0.12 Billion-27.46%
2020-NZ$0.16 Billion-29.78%
2019-NZ$0.23 Billion-13.8%
2018-NZ$0.26 Billion21.98%
2017-NZ$0.22 Billion79.92%
2016-NZ$0.12 Billion53.34%
2015-NZ$76.76 Million69.98%
2014-NZ$45.16 Million51.72%
2013-NZ$29.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.35 B-40,907.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.88 B-15,029.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$6.31 M-104.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$70.18 M-152.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.26 Million-87.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
-NZ$14.49 Million-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-NZ$0.11 Billion-20.90%๐Ÿ‡บ๐Ÿ‡ธ USA